Acoustic and kinetic behaviour of definity in mice exposed to high frequency ultrasound.
Microbubble contrast agents have shown clinical potential for characterising blood flow using 1 to 10 MHz ultrasound; however, scaling their use for similar applications in the mouse with high frequency ultrasound (20 to 60 MHz) has not been addressed. The goal was to determine the utility of microbubbles for mouse imaging with 30 MHz ultrasound by investigating their attenuation and backscatter characteristics as a function of concentration in vitro and dose response in vivo. The agent was exposed to a 30 MHz, 20% bandwidth pulse with a peak negative pressure of 244 kPa. In vitro results showed that the attenuation and backscatter increased linearly for concentrations between 2.8 x 10(6) and 28 x 10(6) bubbles per mL of deionized water. In vivo experiments where performed in the jugular vein of CD-1 mice and time intensity curves were acquired for doses between 10 and 100 microL kg(-1). These doses corresponded to the range of concentrations used in vitro. In vivo results showed that the peak enhancement of the agent increased linearly for doses between 10 and 60 microL kg(-1), the duration of enhancement varied between 200 to 300 s and the integrated enhancement (area under the curve) increased linearly up to 100 microL kg(-1). A maximum enhancement of 13 dB over the blood pool was observed for a dose of 100 microL kg(-1). The intra- and inter-mouse variabilities were 10% to 40% and indicate that further optimisations are required. These results suggest that quantitative contrast flow studies in the mouse using high frequency ultrasound are possible for doses between 10 and 60 microL kg(-1).
Stapleton
Shawn
S
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. shawns@swri.ca
Goodman
Heather
H
Zhou
Yu-Qing
YQ
Cherin
Emmanuel
E
Henkelman
R Mark
RM
Burns
Peter N
PN
Foster
F Stuart
FS
D000818:Animals; D003287:Contrast Media / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005466:Fluorocarbons / Q000494:pharmacology*; D006339:Heart Rate / Q000502:physiology; D007601:Jugular Veins / Q000000981:diagnostic imaging / Q000503:physiopathology; D051379:Mice; D008863:Microspheres; D009068:Movement; D011897:Random Allocation; D012542:Scattering, Radiation; D013997:Time Factors; D014465:Ultrasonics; D014463:Ultrasonography
D003287:Contrast Media; D005466:Fluorocarbons; C042852:perflutren